Peer Review Policy and Reviewer Guidelines
The GSC Biological and Pharmaceutical Sciences (GSCBPS) is committed to maintaining the highest standards of scientific integrity, research quality, and publication ethics through a rigorous, transparent, and impartial peer review process. Peer review serves as the foundation of scholarly publishing by ensuring that every manuscript accepted for publication meets internationally recognized standards of scientific validity, originality, methodological rigor, and ethical compliance.
Our peer review policy has been developed to promote fairness, objectivity, confidentiality, and academic excellence while supporting authors in improving the quality and impact of their research. Every manuscript submitted to GSCBPS is evaluated by qualified experts with relevant subject expertise who provide independent, constructive, and evidence-based recommendations to assist the Editorial Board in making informed publication decisions.
GSCBPS publishes original research articles, review articles, short communications, case reports, and other scholarly contributions in the fields of biological sciences, pharmaceutical sciences, medicine, healthcare, biotechnology, microbiology, pharmacology, toxicology, clinical sciences, and related interdisciplinary research. The peer review process ensures that every published article contributes meaningfully to scientific knowledge while maintaining the integrity of the academic record.
Objectives of the Peer Review Policy
The primary objective of peer review is not only to determine whether a manuscript is suitable for publication but also to help authors improve the scientific quality, clarity, and overall presentation of their research. Independent expert evaluation helps identify strengths, weaknesses, methodological limitations, ethical concerns, and opportunities for improvement before publication.
Through its peer review policy, GSCBPS aims to:
- β Maintain high scientific and publication standards.
- β Ensure originality, novelty, and academic integrity.
- β Improve manuscript quality through constructive reviewer feedback.
- β Support fair, objective, and unbiased editorial decisions.
- β Detect potential ethical concerns, plagiarism, duplicate publication, or research misconduct.
- β Publish reliable, reproducible, and scientifically sound research.
- β Promote transparency, confidentiality, and professionalism throughout the review process.
Commitment to Fair and Independent Peer Review
GSC Biological and Pharmaceutical Sciences believes that editorial decisions should be based exclusively on the scientific merit of a manuscript. Editorial evaluation is conducted without discrimination based on nationality, ethnicity, gender, institutional affiliation, religion, political beliefs, or geographic location of the authors.
Editors and reviewers are expected to evaluate submissions solely on factors such as scientific quality, originality, methodological soundness, ethical compliance, significance of findings, and relevance to the journal's scope. Commercial considerations, publication charges, or other non-scientific factors never influence editorial decisions.
This commitment to editorial independence helps ensure that every manuscript receives a fair, objective, and confidential assessment based entirely on its academic merit.
Peer Review Model
GSC Biological and Pharmaceutical Sciences primarily follows a double-blind peer review system whenever reasonably practicable. Under this model, the identities of authors and reviewers are concealed during the review process to minimize unconscious bias and promote objective scientific evaluation.
Reviewers receive anonymized manuscripts whenever possible and evaluate submissions independently based on scientific quality, originality, research methodology, interpretation of results, ethical compliance, and contribution to existing knowledge. The Editorial Office takes reasonable measures to preserve reviewer and author confidentiality throughout the evaluation process.
When circumstances require alternative review arrangements due to the nature of a submission or limitations in anonymization, the Editorial Office manages the review process while maintaining the principles of fairness, confidentiality, and impartiality.
Reviewer Selection Policy
Selecting qualified reviewers is one of the most important responsibilities of the Editorial Office. GSC Biological and Pharmaceutical Sciences (GSCBPS) appoints reviewers who possess appropriate academic qualifications, subject expertise, research experience, and publication records relevant to the manuscript under evaluation.
Reviewer selection is based on scientific expertise rather than institutional affiliation, nationality, or geographic location. The Editorial Office strives to appoint independent reviewers capable of providing objective, balanced, and constructive evaluations that contribute to maintaining the quality and credibility of published research.
Depending on the manuscript's subject area and complexity, the Editorial Office generally invites at least two independent reviewers. Additional reviewers may be invited whenever further expert opinion is considered necessary or when reviewer recommendations differ significantly.
Reviewer Eligibility Criteria
Individuals invited to review manuscripts should possess sufficient academic and research experience within the relevant discipline. Reviewers are expected to evaluate manuscripts objectively while maintaining the highest standards of scientific integrity and professional ethics.
A reviewer is generally expected to:
- β Hold relevant academic qualifications or equivalent research experience.
- β Demonstrate expertise in the manuscript's subject area.
- β Have an established record of scholarly publications.
- β Maintain independence from the authors.
- β Be capable of providing objective and unbiased scientific evaluations.
- β Respect manuscript confidentiality throughout the review process.
- β Complete the review within the agreed timeframe.
- β Declare any actual or potential conflicts of interest before accepting the review invitation.
The Editorial Office may decline to assign reviewers who have conflicts of interest, insufficient subject expertise, or previous collaborations that could influence the impartiality of the review.
Invitation to Review
Potential reviewers receive an invitation from the Editorial Office containing the manuscript title, abstract, keywords, and other relevant information necessary to determine whether they possess the expertise and availability required to perform the review.
Before accepting the invitation, reviewers are encouraged to carefully assess:
- β Whether the manuscript falls within their area of expertise.
- β Whether they can complete the review within the requested deadline.
- β Whether any personal, professional, institutional, or financial conflicts of interest exist.
- β Whether they can maintain complete confidentiality throughout the review process.
If reviewers believe they are not the most appropriate experts for the manuscript, they are encouraged to decline the invitation promptly. Where appropriate, reviewers may recommend alternative qualified experts who possess relevant subject knowledge.
Reviewer Responsibilities
Reviewers play an essential role in preserving the scientific quality and integrity of scholarly publishing. Their evaluations assist editors in making informed publication decisions while helping authors improve the clarity, accuracy, and overall quality of their manuscripts.
During the review process, reviewers are expected to:
- β Evaluate manuscripts objectively, fairly, and independently.
- β Provide constructive, detailed, and evidence-based comments.
- β Assess originality, novelty, and scientific contribution.
- β Examine research methodology, statistical analysis, and interpretation of results.
- β Identify inconsistencies, weaknesses, or methodological limitations.
- β Suggest practical improvements that strengthen the manuscript.
- β Report suspected plagiarism, duplicate publication, image manipulation, fabricated data, or unethical research practices.
- β Submit review reports within the agreed review period.
- β Maintain professional, respectful, and unbiased communication throughout the review process.
Reviewers should avoid personal criticism of the authors. Comments should focus exclusively on the scientific content of the manuscript and should be written in a respectful, constructive, and professional manner.
Responsibilities of the Editorial Office
The Editorial Office is responsible for managing the peer review process efficiently, fairly, and confidentially. Editors carefully consider reviewer recommendations while exercising independent editorial judgment when making publication decisions.
The Editorial Office is responsible for:
- β Selecting suitably qualified reviewers.
- β Maintaining reviewer confidentiality.
- β Monitoring review timelines.
- β Ensuring fair and unbiased manuscript evaluation.
- β Communicating editorial decisions clearly to authors.
- β Investigating potential ethical concerns when necessary.
- β Maintaining transparency throughout the editorial process.
Editorial decisions are based primarily on scientific merit, reviewer recommendations, publication ethics, methodological quality, and relevance to the aims and scope of GSC Biological and Pharmaceutical Sciences.
Conflicts of Interest
Maintaining objectivity throughout the peer review process is essential to preserving the integrity and credibility of scholarly publishing. GSC Biological and Pharmaceutical Sciences (GSCBPS) requires all reviewers and editors to disclose any actual, potential, or perceived conflicts of interest before participating in the evaluation of a manuscript.
A conflict of interest exists when personal relationships, professional collaborations, institutional affiliations, financial interests, or other circumstances could influenceβor reasonably appear to influenceβthe impartial assessment of a manuscript.
Reviewers should decline an invitation to review if they:
- β Have collaborated or co-authored publications with any of the authors within the recent past.
- β Are employed by or closely affiliated with the same institution as the authors.
- β Have personal, family, academic, or financial relationships that could affect objectivity.
- β Are involved in competing research or commercial activities related to the manuscript.
- β Feel unable to provide an independent and unbiased scientific assessment.
If a potential conflict becomes apparent after accepting the review invitation, the reviewer should immediately inform the Editorial Office. The journal may appoint an alternative reviewer whenever necessary to maintain a fair and impartial review process.
Confidentiality During Peer Review
All manuscripts submitted to GSCBPS are confidential documents. Reviewers receive manuscripts solely for the purpose of scientific evaluation and must not disclose, distribute, copy, or discuss the manuscript with any third party without prior authorization from the Editorial Office.
Information obtained through peer review must never be used for personal research, commercial advantage, academic competition, or any purpose other than the confidential evaluation of the submitted work.
Reviewers are expected to:
- β Treat all manuscript files as confidential.
- β Avoid sharing manuscripts with colleagues or students without editorial permission.
- β Protect confidential data contained within the manuscript.
- β Destroy or permanently delete manuscript files after completing the review if requested by the Editorial Office.
- β Avoid revealing their identity to the authors unless specifically permitted by the journal.
Editors and editorial staff are likewise committed to maintaining strict confidentiality throughout the editorial and peer review process.
Reviewer Ethics and Professional Conduct
Peer reviewers are expected to uphold the highest standards of academic integrity and professional ethics. Reviews should be conducted objectively, respectfully, and solely on the scientific merits of the manuscript.
Constructive criticism is strongly encouraged. Review reports should help authors improve the scientific quality, clarity, methodology, interpretation of results, and presentation of their work. Personal criticism, offensive language, discriminatory remarks, or inappropriate comments are unacceptable.
Reviewers should:
- β Base comments on scientific evidence rather than personal opinion.
- β Provide balanced, detailed, and constructive recommendations.
- β Clearly distinguish major scientific concerns from minor editorial suggestions.
- β Support recommendations with appropriate explanations whenever possible.
- β Maintain professional language throughout the review report.
- β Respect the confidentiality and intellectual property rights of the authors.
Use of Artificial Intelligence (AI) During Peer Review
GSC Biological and Pharmaceutical Sciences recognizes the growing availability of artificial intelligence (AI) technologies. However, peer review requires independent scientific judgment, critical evaluation, ethical reasoning, and subject expertise that cannot be delegated to automated systems.
Reviewers should exercise caution when using AI-assisted tools during the review process. Confidential manuscripts or unpublished research data should not be uploaded to publicly accessible AI platforms or third-party services that may retain, reuse, or disclose submitted content without explicit authorization from the journal.
AI tools may assist reviewers with language refinement or grammar suggestions where appropriate; however, the scientific assessment, originality evaluation, ethical considerations, reviewer recommendations, and final review report must always remain the independent responsibility of the reviewer.
The Editorial Office reserves the right to investigate concerns regarding inappropriate use of AI technologies during peer review whenever necessary.
Reporting Ethical Concerns
If reviewers identify potential ethical issues during manuscript evaluation, they should notify the Editorial Office as soon as possible. Ethical concerns may include plagiarism, duplicate publication, image manipulation, fabricated or falsified data, inappropriate citations, undeclared conflicts of interest, authorship disputes, unethical research practices, or other forms of research misconduct.
All reported concerns are handled confidentially and investigated according to internationally recognized publication ethics principles and the journal's editorial policies. Where appropriate, the Editorial Office may request additional information from authors, seek further expert advice, or take corrective editorial actions to safeguard the integrity of the scientific record.
Evaluation Criteria Used by Reviewers
Reviewers are requested to evaluate each manuscript objectively using recognized scientific standards. The purpose of peer review is to determine whether the submitted work is scientifically sound, ethically conducted, relevant to the journal's scope, and capable of making a meaningful contribution to biological, pharmaceutical, medical, healthcare, or related scientific disciplines.
During the evaluation process, reviewers generally assess the following aspects:
- β Originality and novelty of the research.
- β Relevance to the aims and scope of GSC Biological and Pharmaceutical Sciences.
- β Scientific significance and contribution to existing knowledge.
- β Quality of the research design and methodology.
- β Appropriateness of statistical analysis and data interpretation.
- β Accuracy and reliability of experimental procedures.
- β Ethical compliance for studies involving humans, animals, or biological materials.
- β Adequacy of references and citation of previous literature.
- β Organization, clarity, and readability of the manuscript.
- β Validity of conclusions based on the presented evidence.
- β Overall suitability for publication.
Reviewers are encouraged to distinguish between major scientific concerns and minor editorial suggestions. Recommendations should always be supported by clear explanations that assist both the Editorial Office and the authors.
Reviewer Recommendations
After completing the scientific evaluation, reviewers submit a recommendation to the Editorial Office. Reviewer recommendations serve as expert advice and are carefully considered by the handling editor; however, the final publication decision always remains the responsibility of the Editorial Board.
Reviewer recommendations generally include one of the following:
- β Accept without Revision β The manuscript meets the journal's scientific and editorial standards and is suitable for publication in its current form.
- β Minor Revision β The manuscript requires only small corrections or clarifications before publication.
- β Major Revision β Significant improvements are necessary before the manuscript can be reconsidered for publication.
- β Reject β The manuscript contains major scientific, methodological, ethical, or scope-related issues that prevent publication.
The Editorial Office carefully evaluates reviewer comments together with its independent editorial assessment before communicating a final decision to the corresponding author.
Editorial Independence
GSC Biological and Pharmaceutical Sciences is committed to maintaining complete editorial independence. Editorial decisions are made solely on the basis of scientific quality, originality, methodological rigor, ethical compliance, and relevance to the journal's scope.
Editorial decisions are never influenced by commercial interests, publication charges, institutional affiliations, nationality, funding sources, political opinions, religious beliefs, gender, or any other non-scientific consideration.
Editors are expected to exercise independent professional judgment while respecting reviewer recommendations, publication ethics, and internationally accepted editorial best practices.
Compliance with International Publication Ethics
GSC Biological and Pharmaceutical Sciences follows internationally recognized principles of publication ethics and research integrity. The journal continuously strives to maintain transparency, fairness, accountability, and scientific excellence throughout the editorial and peer review process.
The journal supports internationally accepted recommendations and best practices promoted by organizations including:
- β Committee on Publication Ethics (COPE)
- β International Committee of Medical Journal Editors (ICMJE)
- β Principles of responsible scholarly publishing.
- β International standards for research integrity and ethical publication.
Authors, reviewers, and editors are expected to cooperate in maintaining these standards throughout the publication process. Any suspected breach of publication ethics is investigated carefully by the Editorial Office and handled according to established journal policies.
Why a Rigorous Peer Review Process Matters
A transparent and well-managed peer review system benefits authors, reviewers, readers, and the wider scientific community. Independent scientific evaluation helps improve manuscript quality, strengthens research credibility, increases confidence in published findings, and supports the advancement of reliable scientific knowledge.
For authors, constructive peer review often leads to clearer presentation, stronger methodology, improved interpretation of results, and greater international visibility after publication. For readers, rigorous peer review provides additional confidence that published articles have undergone careful scientific evaluation before acceptance.
By maintaining a robust peer review policy, GSC Biological and Pharmaceutical Sciences continues its commitment to publishing reliable, ethically conducted, and high-quality research that contributes to biological sciences, pharmaceutical sciences, medicine, healthcare, and related disciplines worldwide.
Publish Your Research with Confidence
Selecting the right journal is an important step in the research publication journey. GSC Biological and Pharmaceutical Sciences (GSCBPS) is committed to providing authors with a transparent, ethical, and efficient publication experience supported by rigorous peer review and professional editorial management.
Researchers from universities, research institutions, hospitals, pharmaceutical industries, biotechnology organizations, healthcare institutions, and independent research centers are invited to submit original, high-quality manuscripts for consideration. Every submission is evaluated fairly based on its scientific merit, originality, methodological quality, and relevance to the journal's scope.
Authors publishing with GSCBPS benefit from:
- π Fast Editorial Screening
- π¨ββοΈ Rigorous Double-Blind Peer Review
- π¬ International Peer-Reviewed Journal
- π Crossref DOI Assignment for Every Published Article
- π Worldwide Open Access Publication
- π° Affordable Publication Charges
- π Free Publication Certificate
- π Global Research Visibility
- βοΈ Transparent Editorial Policies
- π‘οΈ Strong Commitment to Publication Ethics
Our Editorial Board is dedicated to maintaining high scientific standards while providing authors with constructive reviewer feedback that enhances the quality, clarity, and impact of published research.
Frequently Asked Questions (FAQs)
What type of peer review does GSCBPS use?
GSC Biological and Pharmaceutical Sciences primarily follows a double-blind peer review process whenever reasonably practicable to ensure objective, confidential, and unbiased manuscript evaluation.
How many reviewers evaluate each manuscript?
Most manuscripts are reviewed by at least two independent experts. Additional reviewers may be invited if further specialist opinions are required.
Can reviewers reject a manuscript?
Reviewers provide recommendations based on scientific evaluation. The final editorial decision is made independently by the Editor or Editorial Board after considering all reviewer comments.
Are reviewers required to declare conflicts of interest?
Yes. Reviewers must disclose any actual or potential conflicts of interest before accepting a review invitation to ensure a fair and transparent review process.
Are review reports confidential?
Yes. All manuscripts and reviewer reports are treated as confidential documents throughout the peer review process.
Can authors appeal an editorial decision?
Authors may submit a reasoned appeal if they believe an editorial decision resulted from a procedural error or factual misunderstanding. Appeals are reviewed independently by the Editorial Office.
Why should I publish with GSCBPS?
GSCBPS offers rigorous peer review, transparent editorial policies, fast editorial processing, affordable publication charges, Open Access publishing, Crossref DOI assignment, and worldwide visibility for published research.